Open-Label, Single-Center, Phase I Trial to Investigate the Mass Balance and Absolute Bioavailability of the Highly Selective Oral MET Inhibitor Tepotinib in Healthy Volunteers

Investigational New Drugs - Netherlands
doi 10.1007/s10637-020-00926-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search